Clinical Trials Sponsored by Genentech
Total 1589 results
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, France
-
AbbVieGenentech, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
AbbVieGenentech, Inc.Completed
-
AmgenGenentech, Inc.Completed
-
Genentech, Inc.BiogenCompletedRheumatoid ArthritisUnited States, Puerto Rico
-
AbbottGenentech, Inc.CompletedHealthy Female SubjectsUnited States
-
AbbVieRoche-GenentechActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, China, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Russian Federation, Singapore, Spain, Sweden, Turkey, Ukraine, United Kingdom
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
AbbVieGenentech, Inc.Active, not recruiting
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia
-
AbbVieRoche-GenentechCompletedNon-Hodgkin's Lymphoma | Neuroblastoma | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | MalignanciesUnited States, Australia, Canada, France, Germany, Netherlands, Switzerland, United Kingdom
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Australia
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | 17p Deletion | Cancer of the Blood and Bone MarrowUnited States, Australia, Canada, France, Germany, Poland, United Kingdom
-
NovartisGenentech, Inc.Completed
-
AbbVieGenentech, Inc.WithdrawnRelapsed/Refractory Non-Hodgkin's Lymphoma
-
AbbottGenentech, Inc.CompletedSolid TumorUnited States, Netherlands, United Kingdom
-
Genentech, Inc.AmgenTerminated
-
NovartisGenentech, Inc.Completed
-
Genentech, Inc.BioNTech SERecruiting
-
Yale UniversityGenentech, Inc.RecruitingHepatocellular Carcinoma | BCLC Stage B Hepatocellular CarcinomaUnited States
-
Columbia UniversityGenentech, Inc.RecruitingSpinal Muscular AtrophyUnited States
-
Georgetown UniversityGenentech, Inc.RecruitingNon-squamous Non-small-cell Lung CancerUnited States
-
Columbia UniversityGenentech, Inc.Recruiting
-
Columbia UniversityGenentech, Inc.RecruitingAdvanced Solid Tumor | Immune-related Adverse EventsUnited States
-
Mayo ClinicGenentech, Inc.TerminatedMicroscopic Polyangiitis | Granulomatosis With Polyangiitis | ANCA Associated VasculitisUnited States
-
Genentech, Inc.BioNTech SEActive, not recruitingMelanoma | Head and Neck Cancer | Colorectal Cancer | Non-Small Cell Lung Cancer | Bladder Cancer | Triple Negative Breast Cancer | Renal Cancer | Other Solid CancersUnited States, Belgium, Sweden, Germany, Canada, Spain, United Kingdom, Netherlands
-
Genentech, Inc.BioNTech SEActive, not recruitingAdvanced MelanomaUnited States, Spain, Belgium, Australia, Germany, United Kingdom
-
Columbia UniversityGenentech, Inc.Active, not recruiting
-
Yale UniversityGenentech, Inc.CompletedEndometrial CancerUnited States
-
Genentech, Inc.Seagen Inc.Completed
-
AbbVieGenentech, Inc.; AmgenTerminatedAcute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States, Australia, Germany
-
Lahey ClinicGenentech, Inc.Completed
-
Northwestern UniversityGenentech, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Geisinger ClinicGenentech, Inc.TerminatedHead and Neck CancerUnited States
-
Mayo ClinicGenentech, Inc.CompletedFibrillary GlomerulonephritisUnited States
-
Georgetown UniversityGenentech, Inc.CompletedPulmonary InfectionsUnited States
-
NovartisGenentech, Inc.; TanoxCompletedAsthmaCanada, Germany, Spain, Belgium, Switzerland, Israel, Portugal, Greece, Hungary, Poland, Ireland, Norway, Denmark, Sweden, Italy, United Kingdom, Turkey
-
Stanford UniversityGenentech, Inc.CompletedHypopituitarismUnited States
-
Yale UniversityGenentech, Inc.Completed
-
Georgetown UniversityGenentech, Inc.Terminated
-
Yale UniversityGenentech, Inc.CompletedBreast CancerUnited States
-
PharmatechSanofi; Genentech, Inc.TerminatedNon-small Cell Lung Cancer Stage IIIB | Non-small Cell Lung Cancer Stage IV
-
Indiana UniversityGenentech, Inc.CompletedNeoplasms, Germ Cell and EmbryonalUnited States
-
Duke UniversityGenentech, Inc.CompletedAllergic AsthmaUnited States
-
Mayo ClinicGenentech, Inc.CompletedMembranous NephropathyUnited States
-
Duke UniversityGenentech, Inc.CompletedPancreatic CancerUnited States
-
Genentech, Inc.23andMe, Inc.CompletedBreast Cancer | Glioblastoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Renal Cell CancerUnited States
-
Kaiser PermanenteGenentech, Inc.CompletedAbdominal Abscess | Pelvic AbscessUnited States
-
Seagen Inc.Genentech, Inc.TerminatedLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States, France, Spain, Belgium, Australia, Germany, Poland, Italy, Czech Republic, Hungary
-
Yale UniversityGenentech, Inc.CompletedGastric Cancer | Gastroesophageal CancerUnited States